Search

everythinglearnresearchcommunity

for

Search:↓

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

XIST RNA helps regenerate hair follicles by targeting miR-424 and activating hedgehog signaling.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

Camouflaging agents like hair fibers and wigs significantly improve appearance and self-esteem for most hair loss patients.

A man with Woolly Hair Syndrome had very curly, fragile hair, and doctors used a special scalp examination to diagnose him without invasive tests.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

Taking alfuzosin and finasteride together caused temporary vision loss in a glaucoma patient, but switching to tamsulosin helped.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.